Accuray Incorporated (ARAY) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of Accuray Incorporated and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARAY vs MDXH

growth of $100 · dividends reinvested · last 5y
ARAY -94.4% (-43.8%/yr)MDXH -95.0% (-45.1%/yr)ARAY compounded faster over this window
020406080100Start $10020222023202420252026$6$5
ARAY MDXH

ARAY vs MDXH: by the numbers

  • •ARAY is the larger company ($31M vs $31M market cap).
  • •Both run net losses; ARAY's is the smaller (-12.24% vs -31.07% net margin).
  • •MDXH grew revenue faster over the past five years (42.35% vs 0.28% CAGR).

Metrics side by side

Valuation

MetricARAYMDXH
P/S ratio0.08N/A
P/B ratio0.75N/A

Profitability

MetricARAYMDXH
Gross margin27.73%59.74%
Operating margin-6.58%-14.28%
Net margin-12.24%-31.07%
ROE-117.97%N/A
ROIC-10.09%-15.35%

Growth (annualized)

MetricARAYMDXH
Revenue CAGR (5Y)0.28%42.35%
Total return CAGR (5Y)-39.94%N/A

Frequently asked

Which has grown faster, ARAY or MDXH?
Over the past five years, MDXH grew revenue faster — ARAY at a 0.28% CAGR versus MDXH at 42.35%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.